Different activity of the biological axis VEGF-Flt-1 (fms -like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: A bronchoalveolar lavage study

Clinical and Developmental Immunology

Volumn 2009, Issue , 2009, Pages

  Antoniou, Katerina M ^a   Soufla, Giannoula ^a   Proklou, Athanasia ^a   Margaritopoulos, George ^a   Choulaki, Christiana ^a   Lymbouridou, Rena ^a   Samara, Katerina D ^a   Spandidos, Demetrios A ^a   Siafakas, Nikolaos M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SARCOIDOSIS; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CXC; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, MESSENGER; SARCOIDOSIS, PULMONARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 77749316047     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2009/537929     Document Type: Article

References (35)

1. Turner-Warwick M., Precapillary systemic-pulmonary anastomoses Thorax 1963 18 225 237
2. Strieter R. M., Burdick M. D., Gomperts B. N. et al., CXC chemokines in angiogenesis Cytokine Growth Factor Reviews 2005 16 6 593 609
3. Strieter R. M., Belperio J. A., Keane M. P., CXC chemokines in angiogenesis related to pulmonary fibrosis Chest 2002 122 6, supplement 298S 301S
4. Hunninghake G. W., Costabel U., Ando M., ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Granulomatous Disorders Sarcoidosis Vasculitis and Diffuse Lung Disease 1999 16 2 149 173
5. Agostini C., Meneghin A., Semenzato G., T-lymphocytes and cytokines in sarcoidosis Current Opinion in Pulmonary Medicine 2002 8 5 435 440
6. Petrek M., Kolek V., Szotkowsk J., du Bois R. M., CC and C chemokine expression in pulmonary sarcoidosis European Respiratory Journal 2002 20 5 1206 1212
7. Costabel U., Ohshimo S., Guzman J., Diagnosis of sarcoidosis Current Opinion in Pulmonary Medicine 2008 14 5 455 461
8. Bonecchi R., Bianchi G., Bordignon P. P. et al., Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s The Journal of Experimental Medicine 1998 187 1 129 134
9. Capelli A., Di Stefano A., Lusuardi M., Gnemmi I., Donner C. F., Increased macrophage inflammatory protein-1 and macrophage inflammatory protein-1 levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis American Journal of Respiratory and Critical Care Medicine 2002 165 2 236 241
10. Katchar K., Eklund A., Grunewald J., Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis Journal of Internal Medicine 2003 254 6 564 571
11. Nishioka Y., Manabe K., Kishi J. et al., CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages Clinical and Experimental Immunology 2007 149 2 317 326
12. Antoniou K. M., Tzouvelekis A. et al., Alexandrakis M. G., Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis Chest 2006 130 4 982 988
13. Antoniou K. M., Tzanakis N., Tzortzaki E. G. et al., Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon -1b therapy in idiopathic pulmonary fibrosis patients Pulmonary Pharmacology and Therapeutics 2008 21 6 840 844
14. Voelkel N. F., Vandivier R. W., Tuder R. M., Vascular endothelial growth factor in the lung American Journal of Physiology 2006 290 L209 L221
15. Millauer B., Wizigmann-Voos S., Schnürch H. et al., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 1993 72 6 835 846
16. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias American Journal of Respiratory and Critical Care Medicine 2002 165 2 277 304
17. Quanjer P. H., Tammeling G. J., Cotes J. E. et al., Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society The European Respiratory Journal. Supplement 1993 16 5 40
18. Report of the European Society of Pneumonology Task Group, Technical recommendations and guidelines for bronchoalveolar lavage (BAL) European Respiratory Journal 1989 2 561 585
19. Soulitzis N., Karyotis I., Delakas D., Spandidos D. A., Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia International Journal of Oncology 2006 29 2 305 314
20. Koh H., Tasaka S., Hasegawa N. et al., Vascular endothelial growth factor in epithelial lining fluid of patients with acute respiratory distress syndrome Respirology 2008 13 2 281 284
21. Muller-Quernheim J., Sarcoidosis: immunopathogenetic concepts and their clinical application European Respiratory Journal 1998 12 3 716 738
22. Agostini C., Cassatella M., Zambello R. et al., Involvement of the IP-10 chemokine in sarcoid granulomatous reactions Journal of Immunology 1998 161 11 6413 6420
23. Tsiligianni I., Antoniou K. M., Kyriakou D. et al., Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis BMC Pulmonary Medicine 2005 5, article 8
24. Antoniou K. M., Tzouvelekis A., Alexandrakis M. G. et al., Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis Journal of Interferon and Cytokine Research 2006 26 6 400 405
25. Antoniou K. M., Tsiligianni I., Tzanakis N. et al., Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study Chest 2006 129 6 1592 1598
26. Miotto D., Christodoulopoulos P., Olivenstein R. et al., Expression of IFN-γ-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases Journal of Allergy and Clinical Immunology 2001 107 4 664 670
27. Katoh S., Fukushima K., Matsumoto N. et al., Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia International Archives of Allergy and Immunology 2005 137 3 229 235
28. Busuttil A., Weigt S. S., Keane M. P. et al., CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis European Respiratory Journal 2009 34 3 676 686
29. Sekiya M., Ohwada A., Miura K., Takahashi S., Fukuchi Y., Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis Lung 2003 181 5 259 265
30. Koyama S., Sato E., Haniuda M., Numanami H., Nagai S., Izumi T., Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2002 166 3 382 385
31. Sugiyama K., Mukae H., Ishii H. et al., Elevated levels of interferon -inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis Respirology 2006 11 6 708 714
32. Renzoni E. A., Walsh D. A., Salmon M. et al., Interstitial vascularity in fibrosing alveolitis American Journal of Respiratory and Critical Care Medicine 2003 167 3 438 443
33. Keane M. P., Angiogenesis and pulmonary fibrosis: feast or famine? American Journal of Respiratory and Critical Care Medicine 2004 170 207 209
34. Renzoni E. A., Neovascularization in idiopathic pulmonary fibrosis: too much or too little? American Journal of Respiratory and Critical Care Medicine 2004 169 1179 1180
35. Ebina M., Shimizukawa M., Shibata N. et al., Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2004 169 11 1203 1208